A Study of the Effectiveness and Safety of Ustekinumab (STELARA) and CNTO 1959 Administered Under the Skin of Patients With Active Rheumatoid Arthritis, Despite Existing Methotrexate Therapy
Clinical trial NCT01645280 · COMPLETED
Trial details
- NCT number
- NCT01645280
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2013-12-01
- Enrollment
- 274
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.